Insufficient scRNA-seq data for expression of NGB at single-cell level.
Insufficient scRNA-seq data for expression of NGB at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 92% | 1040.90 | 2428 / 2642 | 45% | 3.87 | 315 / 705 |
adrenal gland | 25% | 210.37 | 65 / 258 | 51% | 65.88 | 117 / 230 |
intestine | 61% | 250.75 | 592 / 966 | 1% | 0.04 | 7 / 527 |
esophagus | 38% | 113.44 | 546 / 1445 | 15% | 1.27 | 28 / 183 |
tonsil | 0% | 0 | 0 / 0 | 36% | 2.77 | 16 / 45 |
uterus | 1% | 1.81 | 2 / 170 | 29% | 4.09 | 133 / 459 |
stomach | 22% | 66.39 | 80 / 359 | 3% | 0.20 | 10 / 286 |
pancreas | 11% | 32.45 | 35 / 328 | 7% | 0.24 | 12 / 178 |
bladder | 0% | 0 | 0 / 21 | 14% | 0.93 | 70 / 504 |
lung | 0% | 0.19 | 1 / 578 | 14% | 0.99 | 158 / 1155 |
ovary | 0% | 0 | 0 / 180 | 10% | 1.32 | 44 / 430 |
thymus | 0% | 0.15 | 1 / 653 | 5% | 1.77 | 30 / 605 |
breast | 0% | 0 | 0 / 459 | 5% | 0.23 | 56 / 1118 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.10 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.02 | 7 / 901 |
prostate | 0% | 0 | 0 / 245 | 0% | 0.00 | 2 / 502 |
skin | 0% | 0.39 | 2 / 1809 | 0% | 0.01 | 1 / 472 |
adipose | 0% | 0.70 | 3 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015671 | Biological process | oxygen transport |
GO_0001666 | Biological process | response to hypoxia |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005344 | Molecular function | oxygen carrier activity |
GO_0019825 | Molecular function | oxygen binding |
GO_0005092 | Molecular function | GDP-dissociation inhibitor activity |
GO_0098809 | Molecular function | nitrite reductase activity |
GO_0020037 | Molecular function | heme binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | NGB |
Protein name | Neuroglobin Neuroglobin (Nitrite reductase) (EC 1.7.-.-) |
Synonyms | hCG_22274 GLNH |
Description | FUNCTION: Monomeric globin with a bis-histidyl six-coordinate heme-iron atom through which it can bind dioxygen, carbon monoxide and nitric oxide . Could help transport oxygen and increase its availability to the metabolically active neuronal tissues, though its low quantity in tissues as well as its high affinity for dioxygen, which may limit its oxygen-releasing ability, argue against it . The ferrous/deoxygenated form exhibits a nitrite reductase activity and it could produce nitric oxide which in turn inhibits cellular respiration in response to hypoxia . In its ferrous/deoxygenated state, it may also exhibit GDI (Guanine nucleotide Dissociation Inhibitor) activity toward heterotrimeric G-alpha proteins, thereby regulating signal transduction to facilitate neuroprotective responses in the wake of hypoxia and associated oxidative stress . . |
Accessions | ENST00000298352.5 Q9NPG2 A0M8W9 |